when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
drugs
Divalproex Sodium

drug

divalproex sodium DR

Marketedupdated 3mo ago

by Inva-Tech Pharma Solutions LLC

Approved

community read0 votes

🐶 often sniffed alongside

top 8

tagApproval378 co-mentions · 189 sources
drugDEPAKOTE334 co-mentions · 190 sources
drugDEPAKOTE ER334 co-mentions · 190 sources
drugDIVALPROEX SODIUM190 co-mentions · 190 sources
drugDivalproex Sodium DR Viatris190 co-mentions · 190 sources
drugdivalproex sodium ER190 co-mentions · 190 sources
tagSmall Molecule189 co-mentions · 189 sources
drugVALPROIC ACID144 co-mentions · 144 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 15 investigational indications.

indications

investigational

Epilepsy

all catalysts(100)

approval · 100

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

DIVALPROEX SODIUM — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

DIVALPROEX SODIUM — FDA approval

divalproex sodium DR

DIVALPROEX SODIUM — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

DIVALPROEX SODIUM — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

$ABBV261.83-1.56%

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

divalproex sodium DR

view all 100 catalysts →

Trials studying divalproex sodium DR

phase2Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Carecruitingn=83
phase4Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?completedn=60

News(0)

no news has mentioned this drug yet

brand

Divalproex Sodium

generic

divalproex sodium

MOA

12.1 Mechanism of Action Divalproex sodium dissociates to the valproate ion in the gastrointestinal tract. The mechanisms by which valproate exerts its therapeutic effects have not been established. It has been suggested that its activity in epilepsy is related to increased brain concentrations of gamma-aminobutyric acid (GABA).

indication

Absence Seizure

phase

marketed

Data sources

openFDA · ClinicalTrials.gov

last refreshed 13m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?